The natural course of atopic dermatitis from birth to age 7 years and the association with asthma - PubMed (original) (raw)
Multicenter Study
. 2004 May;113(5):925-31.
doi: 10.1016/j.jaci.2004.01.778.
Affiliations
- PMID: 15131576
- DOI: 10.1016/j.jaci.2004.01.778
Multicenter Study
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma
Sabina Illi et al. J Allergy Clin Immunol. 2004 May.
Abstract
Background: Atopic dermatitis (AD) is considered to be one of the first manifestations in the atopic march. However, few prospective studies on AD and its association with childhood asthma exist.
Objective: The aim of this study was to prospectively investigate the natural course of AD to determine factors influencing its prognosis and to analyze the relationship of AD with childhood asthma.
Methods: The Multicenter Allergy Study, a German birth cohort, followed 1314 children from birth to age 7 years. Physical examinations, parental interviews on atopic symptoms and diagnoses, and determination of specific IgE levels were performed regularly.
Results: The cumulative prevalence of AD in the first 2 years of life was 21.5%. Of these children with early AD, 43.2% were in complete remission by age 3 years, 38.3% had an intermittent pattern of disease, and 18.7% had symptoms of AD every year. Severity (adjusted cumulative odds ratio, 5.86; 95% CI, 3.04-11.29) and atopic sensitization (adjusted cumulative odds ratio, 2.76; 95% CI, 1.29-5.91) were major determinants of prognosis. Early wheeze and a specific sensitization pattern were significant predictors for wheezing at school age, irrespective of AD. Early AD without these cofactors constituted no increased risk of subsequent wheeze (adjusted odds ratio, 1.11; 95% CI, 0.56-2.20) or bronchial hyperreactivity.
Conclusion: AD is a common condition in infancy but disappears around age 3 years in a significant proportion of children. The prognosis is mostly determined by the severity and the presence of atopic sensitization. Early AD is associated with asthma at school age, but in many of these asthmatic children, wheezing manifests before or with the onset of AD. Children with AD and wheeze have a marked loss in lung function, suggesting a distinct phenotype rather than a progressive development from AD to asthma.
Similar articles
- The pattern of atopic sensitization is associated with the development of asthma in childhood.
Illi S, von Mutius E, Lau S, Nickel R, Niggemann B, Sommerfeld C, Wahn U; Multicenter Allergy Study Group. Illi S, et al. J Allergy Clin Immunol. 2001 Nov;108(5):709-14. doi: 10.1067/mai.2001.118786. J Allergy Clin Immunol. 2001. PMID: 11692093 - Development of atopic dermatitis during the first 3 years of life: the Copenhagen prospective study on asthma in childhood cohort study in high-risk children.
Halkjaer LB, Loland L, Buchvald FF, Agner T, Skov L, Strand M, Bisgaard H. Halkjaer LB, et al. Arch Dermatol. 2006 May;142(5):561-6. doi: 10.1001/archderm.142.5.561. Arch Dermatol. 2006. PMID: 16702493 - Risk factors for atopic dermatitis in New Zealand children at 3.5 years of age.
Purvis DJ, Thompson JM, Clark PM, Robinson E, Black PN, Wild CJ, Mitchell EA. Purvis DJ, et al. Br J Dermatol. 2005 Apr;152(4):742-9. doi: 10.1111/j.1365-2133.2005.06540.x. Br J Dermatol. 2005. PMID: 15840107 - [From atopic dermatitis to asthma].
Marín A, Eseverri JL, Botey J. Marín A, et al. Allergol Immunopathol (Madr). 1998 May-Jun;26(3):114-9. Allergol Immunopathol (Madr). 1998. PMID: 9675392 Review. Spanish. - Epidemiology of atopic dermatitis and atopic march in children.
Spergel JM. Spergel JM. Immunol Allergy Clin North Am. 2010 Aug;30(3):269-80. doi: 10.1016/j.iac.2010.06.003. Immunol Allergy Clin North Am. 2010. PMID: 20670812 Review.
Cited by
- Global, regional, and national burdens of atopic dermatitis under 14: a trend analysis and future prediction based on the global burden of disease study 2019.
Wang Z, Liang X, Li X, Zhou Z, Zhang Z, Zhao J, Gao X. Wang Z, et al. Arch Dermatol Res. 2024 Jul 10;316(7):463. doi: 10.1007/s00403-024-03195-7. Arch Dermatol Res. 2024. PMID: 38985170 - Vinpocetine, a phosphodiesterase 1 inhibitor, mitigates atopic dermatitis-like skin inflammation.
Lee YJ, Song JY, Lee SH, Lee Y, Hwang KT, Lee JY. Lee YJ, et al. Korean J Physiol Pharmacol. 2024 Jul 1;28(4):303-312. doi: 10.4196/kjpp.2024.28.4.303. Korean J Physiol Pharmacol. 2024. PMID: 38926838 Free PMC article. - Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.
Paller AS, Siegfried EC, Simpson EL, Cork MJ, Sidbury R, Chen IH, Khokhar FA, Xiao J, Dubost-Brama A, Bansal A. Paller AS, et al. Am J Clin Dermatol. 2024 Jul;25(4):655-668. doi: 10.1007/s40257-024-00859-y. Epub 2024 May 14. Am J Clin Dermatol. 2024. PMID: 38743155 Free PMC article. Clinical Trial. - Redefining the Role of Nutrition in Infant Food Allergy Prevention: A Narrative Review.
Brandwein M, Enten Vissoker R, Jackson H, Rogan T, Pitcock J, Krinkin E, Venter C. Brandwein M, et al. Nutrients. 2024 Mar 14;16(6):838. doi: 10.3390/nu16060838. Nutrients. 2024. PMID: 38542749 Free PMC article. Review. - Understanding the heterogeneity of childhood allergic sensitization and its relationship with asthma.
Custovic A, Custovic D, Fontanella S. Custovic A, et al. Curr Opin Allergy Clin Immunol. 2024 Apr 1;24(2):79-87. doi: 10.1097/ACI.0000000000000967. Epub 2024 Feb 7. Curr Opin Allergy Clin Immunol. 2024. PMID: 38359101 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical